SCHEMBL13768396

SCHEMBL13768396

CCC(=O)N1CCC(NC(=O)NC23CC4CCCC(C2)C(C4)C3)CC1

nearest known ligand 0.74

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 19/20 0.74
EPHX1 P07099 13/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13768770 0.88 EPHX2 (0.57) EPHX2EPHX1
SCHEMBL13768762 0.88 EPHX2 (0.58) EPHX2EPHX1
SCHEMBL13768778 0.88 EPHX2 (0.60) EPHX2EPHX1
SCHEMBL13768759 0.87 EPHX2 (0.57) EPHX2EPHX1
SCHEMBL13768777 0.86 EPHX2 (0.56) EPHX2EPHX1
SCHEMBL13768763 0.86 EPHX2 (0.62) EPHX2EPHX1
SCHEMBL2731282 0.86 EPHX2 (1.00) EPHX2EPHX1
SCHEMBL13768780 0.83 EPHX2 (0.67) EPHX2EPHX1
SCHEMBL13768766 0.81 EPHX2 (0.57) EPHX2EPHX1
SCHEMBL13768771 0.79 EPHX2 (0.58) EPHX2EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009086426-A2 SOLUBLE EPOXIDE HYDROLASE INHIBITORS FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION ARETE THERAPEUTICS, INC. (US) 2009-07-09 WO disclosed
WO-2008112022-A1 4 -PI PERIDINYLUREA COMPOUNDS AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS ARETE THERAPEUTICS, INC. (US) 2008-09-18 WO disclosed